-->

NICE inContact CXone Expands Artificial Intelligence Apps with Speech-Enabled Virtual Assistants and AI Chatbots from Omilia

NICE inContact announced the expansion of its artificial intelligence applications with the Omilia conversational technology stack on CXexchange, an extensive marketplace featuring ready-to-use applications designed to integrate with NICE inContact CXone. The Omilia conversational technology stack for organizations using CXone leverages artificial intelligence and automation that provides easy-to-deploy speech-enabled virtual assistants and AI chatbots.

NICE inContact CXone customers will benefit from Omilia’s conversational AI technology stack by enabling:

  • Conversational customer care for voice and digital channels
  • Voice biometrics for passive and dynamic conversational authentication
  • Advanced speech analytics

Companies using CXone and the Omilia application can deploy next generation conversational customer care portals over all channels using one single cloud customer experience platform — designing and training Omilia artificial intelligence once and deploying the same application on all channels, all while keeping precious customer data in one unified location.

DEVone offers partners broad tools and resources to enable independent software vendors (ISVs) like Omilia to create new applications on CXone, including extensive documentation and support, and access to an online developer community. Companies interested in how Omilia’s application works with CXone can visit CXexchange to learn more about the application and read reviews. CXexchange is a centralized, state-of-the-art marketplace for developers to market and sell their applications ready-to-integrate easily with CXone.

SpeechTek Covers
Free
for qualified subscribers
Subscribe Now Current Issue Past Issues
Related Articles

Sonde Health Announces Patents Covering Methods of Detecting Vocal Biomarkers in Physical or Psychological Conditions

Sonde Health Inc., an affiliate of PureTech Health developing a voice-based technology platform for monitoring and diagnosing mental and physical medical conditions, announced that the United States Patent and Trademark Office and Intellectual Property Australia have issued the company patents.